Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is seeking an Executive Director, Patents to lead intellectual property strategy for their patent portfolio. The role involves developing and integrating global prosecution and challenge strategies, as well as partnering with senior leadership to inform business decisions.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines